These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30691616)

  • 1. High prevalence of currently circulating Bordetella pertussis isolates not producing vaccine antigen pertactin in Slovenia.
    Kastrin T; Barkoff AM; Paragi M; Vitek MG; Mertsola J; He Q
    Clin Microbiol Infect; 2019 Feb; 25(2):258-260. PubMed ID: 30691616
    [No Abstract]   [Full Text] [Related]  

  • 2. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland.
    Barkoff AM; Mertsola J; Guillot S; Guiso N; Berbers G; He Q
    Clin Vaccine Immunol; 2012 Oct; 19(10):1703-4. PubMed ID: 22914363
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.
    Isacson J; Trollfors B; Taranger J; Lagergård T
    Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertactin-deficient
    Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim D; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; He Q
    Euro Surveill; 2019 Feb; 24(7):. PubMed ID: 30782265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whooping cough in South-East Romania: a 1-year study.
    Dinu S; Guillot S; Dragomirescu CC; Brun D; Lazăr S; Vancea G; Ionescu BM; Gherman MF; Bjerkestrand AF; Ungureanu V; Guiso N; Damian M
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):302-6. PubMed ID: 24355701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines.
    Hegerle N; Guiso N
    Expert Rev Vaccines; 2014 Sep; 13(9):1135-46. PubMed ID: 24953157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pertactin-negative variants of Bordetella pertussis in New York State: a retrospective analysis, 2004-2013.
    Quinlan T; Musser KA; Currenti SA; Zansky SM; Halse TA
    Mol Cell Probes; 2014 Aug; 28(4):138-40. PubMed ID: 24365130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
    Bailon H; León-Janampa N; Padilla C; Hozbor D
    BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of an acellular pertussis vaccine composed of genetically inactivated pertussis toxin combined with filamentous hemagglutinin and pertactin in infants and children.
    Podda A; Carapella De Luca E; Titone L; Casadei AM; Cascio A; Bartalini M; Volpini G; Peppoloni S; Marsili I; Nencioni L
    J Pediatr; 1993 Jul; 123(1):81-4. PubMed ID: 8320630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination.
    Polak M; Zasada AA; Mosiej E; Krysztopa-Grzybowska K; Witkowski L; Rzeczkowska M; Piekarska K; Lutyńska A
    Microbes Infect; 2019; 21(3-4):170-175. PubMed ID: 30580013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin.
    Williams MM; Sen K; Weigand MR; Skoff TH; Cunningham VA; Halse TA; Tondella ML;
    Emerg Infect Dis; 2016 Feb; 22(2):319-322. PubMed ID: 26812174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and molecular characterization of pertactin-deficient Bordetella pertussis in the United States.
    Pawloski LC; Queenan AM; Cassiday PK; Lynch AS; Harrison MJ; Shang W; Williams MM; Bowden KE; Burgos-Rivera B; Qin X; Messonnier N; Tondella ML
    Clin Vaccine Immunol; 2014 Feb; 21(2):119-25. PubMed ID: 24256623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis.
    Trollfors B; Zackrisson G; Taranger J; Lagergård T
    J Pediatr; 1992 Jun; 120(6):924-6. PubMed ID: 1593352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.
    Weber C; Boursaux-Eude C; Coralie G; Caro V; Guiso N
    J Clin Microbiol; 2001 Dec; 39(12):4396-403. PubMed ID: 11724851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and antigenic analysis of Bordetella pertussis isolates recovered from clinical cases in Ontario, Canada, before and after the introduction of the acellular pertussis vaccine.
    Tsang RS; Sill ML; Martin IE; Jamieson F
    Can J Microbiol; 2005 Oct; 51(10):887-92. PubMed ID: 16333349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014.
    Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS
    Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
    Socan M; Prosenc K; Vegnuti M
    Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.